These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 12732086)
1. Prognostic significance of serum squamous cell carcinoma antigen in surgically treated lung cancer. Takeuchi S; Nonaka M; Kadokura M; Takaba T Ann Thorac Cardiovasc Surg; 2003 Apr; 9(2):98-104. PubMed ID: 12732086 [TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung]. Zeng L Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022 [TBL] [Abstract][Full Text] [Related]
3. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976 [TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer. Abe A; Nakano T; Morita S; Oka K Anticancer Res; 1999; 19(1B):829-36. PubMed ID: 10216501 [TBL] [Abstract][Full Text] [Related]
5. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815 [TBL] [Abstract][Full Text] [Related]
6. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660 [TBL] [Abstract][Full Text] [Related]
7. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen. Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246 [TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer. Hefler LA; Sliutz G; Leodolter S; Speiser P; Joura E; Reinthaller A; Kohlberger P Gynecol Oncol; 2005 Jun; 97(3):904-7. PubMed ID: 15894354 [TBL] [Abstract][Full Text] [Related]
9. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer. Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121 [TBL] [Abstract][Full Text] [Related]
10. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma. Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125 [TBL] [Abstract][Full Text] [Related]
14. Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma. Honma H; Kanda T; Ito H; Wakai T; Nakagawa S; Ohashi M; Koyama Y; Valera VA; Akazawa K; Hatakeyama K Surgery; 2006 May; 139(5):678-85. PubMed ID: 16701102 [TBL] [Abstract][Full Text] [Related]
15. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma. Nikliński J; Furman M; Laudański J; Kozłowski M Neoplasma; 1992; 39(5):279-82. PubMed ID: 1331826 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma. Bolger BS; Dabbas M; Lopes A; Monaghan JM Gynecol Oncol; 1997 May; 65(2):309-13. PubMed ID: 9159343 [TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma. Zhao Y; Jiang Y; Wang R; Zheng X; Wang X; Jin B; Lu Y; Qiao T; Hong L; Fan D Ann Surg Oncol; 2007 Sep; 14(9):2621-7. PubMed ID: 17570016 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer. Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383 [TBL] [Abstract][Full Text] [Related]
20. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer. Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]